Pioneering the Future of Human Longevity
Celljevity is dedicated to reversing aging, not just treating it. The company integrates cellular rejuvenation technology and AI-powered health optimization.
Our Mission
Democratizing Longevity Science
From Lab Discovery to Global Access—The Celljevity Story
Humanitarian Commitment
Tiered pricing based on location to maintain profitability while expanding access.
Beyond Anti-Aging
Preventive healthcare reimagined. Delaying Alzheimer's onset by 5 years saves global economies billions.
Our Foundation
The principles that guide our mission to make longevity accessible to all
Vision • Mission • Promise
Vision
A world where aging is a choice, not an inevitability
Mission
To reverse biological aging through safe, proven cellular rejuvenation technology
Promise
Evidence-based treatments with uncompromising safety standards
Core Values
Scientific Integrity
Every claim backed by data
Safety
Zero compromise on safety protocols
Innovation
Continuously advancing the science
Accessibility
Working to democratize longevity
Transparency
Open about our methods and results
Join Our Mission
Whether you're a patient, healthcare provider, researcher, or investor, we invite you to be part of the longevity revolution.
Our Team
World-Class Leadership
Led by experienced executives and guided by distinguished advisors
Leadership Team
Diederik van der Reijt
Chief Executive Officer
Serial biotech entrepreneur and investor founded Celljevity (cellular rejuvenation) and co-founded NKore Biotherapeutics (immunotherapies). Leveraging his background in trading and venture capital, he aims to scale science-backed innovations and democratize access to breakthrough cellular therapies.
Dr. Henk Viëtor
Chief Medical Officer
Co-founded and led more than 20 life sciences companies, including Drug Discovery Factory, Skyline Diagnostics, Julius Clinical, DC4U, MyLife Technologies, and Oncodrone. Physician, scientist, and serial biotech entrepreneur with expertise in clinical immunology, transfusion medicine, and genetics.
David Maman
Chief Operational Officer
Serial entrepreneur, involved in creating startups and projects since the 90s. Worked in Paris, London, New York, Dubai, Abu Dhabi, Luxembourg, Tel Aviv etc. Since 2000s, held executive positions in several international groups.
Dr. Digvijay Gahtory
Chief Business Officer
Has over 8 years of experience in strategy consulting and entrepreneurship. Has raised more than €100 million in financing for life science companies. Founder and CEO of Bimini Biotech.
Karen Brink
Chief Growth Officer
Focuses on growth strategies and thought leadership. Skilled and experienced investor who has founded several healthcare companies. Holds a Blockchain Strategy degree from Oxford.
Rhys Tombling
Finance Director
Has 10 years of experience in the private sector, specializing in financial control & operations for start-ups and scale-ups in FMCG and SaaS. Holds an ACA-ICAEW accountancy qualification and a BA in Accountancy and Finance from Newcastle University.
Dan Fobes
Chief Technology Officer
Formerly Senior Director Business Intelligence at Humana, Director of Technology Architecture and Digital at Novartis and Pfizer.
Daniel Erasmus
Chief Artificial Intelligence Architect
Furqan Athar
President MENA Operations
Medical & Scientific Board
Dr. Yi Eve Sun
Chief Science Officer
Professor, UCLA Department of Molecular & Medical Pharmacology. Pioneer in neural stem cell biology and leading expert in cellular reprogramming. Academic excellence with breakthrough discoveries in JAK-STAT pathways and successful translation from bench to bedside.
Dr. Henry Delmar
Founder, Clinic Del Mar
Member of the European Board of Plastic Surgeons (EBOPRAS), specializes in Plastic, Reconstructive, and Aesthetic Surgery. President of the French Society of Aesthetic Plastic Surgery (SOFCEP) and member of IPRAS and ESPRAS.
Dr. Adeel Khan
Board-Certified Physician
Board-certified physician and Co-founder of Minicircle, specializing in stem cell therapy and gene therapy applications. University of Ottawa medical graduate with clinical expertise in regenerative treatments. Through Eterna Health, operates international clinics focusing on cutting-edge longevity interventions.
Dr. Christopher Juel-Jensen
Chief Integration Officer
Surgeon, investment banker, and leader in longevity and regenerative medicine. Combines finance and medicine, previously working at J.P. Morgan, Goldman Sachs, Deutsche Bank, and Swiss Bank Corp., now developing healthcare and wellness platforms worldwide.
Dr. Pierre Maldiney
Cardiologist & Anti-Aging Physician
Cardiologist, morphologist, and anti-aging physician with training in nutritional and functional medicine with Professor Vincent Castronovo. President of AEM2F, the European Association of Mitronutrition and Functional Medicine.
Dr. Lin Quan
Clinical Director, UCLA
Clinical Director for preclinical research, focusing on Auto-rFib therapy research with expertise in cell culture and animal experiments. Leads preclinical investigations for neurodegenerative disease applications.
Doris Rathgeber
Medical Director, Body & Soul
Founder and Medical Director of Body & Soul in Shanghai. With over 20 years' experience in Traditional Chinese and Western Medicine, specializes in women's health, fertility, and pediatrics, delivering care in four languages.
Dr. Murat Bozkurt
Medical Advisor
Advisory Board
Paul Spiegel
Strategic Advisor
International business development executive with extensive experience in Asia-Pacific markets and cross-border partnerships. Specializes in strategic planning and market expansion for biotechnology companies, with deep expertise in regulatory affairs and commercial strategy.
Neil Bush
Senior Advisor
Global business leader with 40+ years experience specializing in cross-border investments in Asia and the Middle East. Founder of the George H. W. Bush Foundation for U.S.-China Relations. Chairs Points of Light and the Bush School Advisory Board.
Anne Popkin
Strategic Advisor
Senior executive and strategic advisor with extensive experience in finance, biotechnology, and investor advocacy. Recognized for leadership roles at major asset management firms and commitment to advancing women's representation in finance. Active philanthropist supporting education, science, and ocean preservation.
Stephen Bradley
Non-Executive Director
Former British Consul-General to Hong Kong, graduated from Oxford in 1980 and studied at Fudan University. Leverages extensive diplomatic experience across Asia to advise on cross-border consultancy and strategic development. Serves on the boards of Cenovus Energy Inc., CK Asset Holdings, and Power Assets Holdings.
Jamie Grooms
Executive Board Member
Highly recognized biotechnology entrepreneur and innovator. Founded and led companies including Synogen, AxoGen, RTI Biologics, and NeXtGen Biologics. Decades of experience as CEO and board member in regenerative medicine, medical devices, and biotech venture capital.
David Bizer
Investment Advisor
Co-founder and Managing Partner of GCW Global Customised Wealth, specializing in private equity and family office investments. Previously held senior positions at Jasper Ridge Partners, Nomura, and Lehman Brothers. Has served as an economic advisor to two U.S. Presidents. Ph.D. in Economics from Stanford University.
Rachid Bouzouba
Co-Founder, MCM Partners
Co-Founder and Chairman of MCM Partners, a Hong Kong-based merchant bank and corporate advisory firm. Accomplished finance executive with extensive leadership in global equities and derivatives, previously serving as Head of Global Equities at Nomura and Head of European Equities at Lehman Brothers.
Shirin Azad
Strategic Advisor
Medical Disclaimer: Celljevity's Prometheus technology is investigational and not FDA-approved. Research protocol options vary by jurisdiction. Individual results may vary. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent disease. Consult your healthcare provider.